Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2003
05/21/2003EP0831703A4 Method of solubilizing and encapsulating itraconazole
05/21/2003EP0820285B1 Methods and compositions for lipidization of hydrophilic molecules
05/21/2003EP0817625B1 Compositions for treatment of photodamaged skin comprising an rar-alpha antagonist and a multi-selective retinoid
05/21/2003EP0797442B1 Treatment of optic neuritis
05/21/2003EP0792148B1 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
05/21/2003EP0785714B2 Antimicrobial composition
05/21/2003EP0735867B1 Transdermal delivery device containing an estrogen
05/21/2003EP0706394B1 Use of a compostion comprising histamine phosphate for the manufacture of a medicament for the topical treatment of epithelial inflammation or lesions
05/21/2003CN1419564A Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
05/21/2003CN1419560A Anti-infective actatm
05/21/2003CN1419559A Tricyclic protein kinase inhibitors
05/21/2003CN1419558A Process for producing camptothecin
05/21/2003CN1419556A Pyrano [2,3-C] imidazo[-1,2-A] pyridine convenant au traitement de troubles gastrointestinal disorders
05/21/2003CN1419554A Process for preparing crystalline form 1 of cabergoline
05/21/2003CN1419553A Prodigiosin-derivatives as neoplastic and anti-viral agents
05/21/2003CN1419552A 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors
05/21/2003CN1419548A 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
05/21/2003CN1419547A Compounds exhibiting thrombopoietin receptor agaonism
05/21/2003CN1419546A 4,5-dihydro-1h-pyrazole derivatives having cbi-antagonistic activity
05/21/2003CN1419545A 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
05/21/2003CN1419542A Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides 403
05/21/2003CN1419541A Pharmaceutically active pyrrolidine derivatives as BAX inhibitors
05/21/2003CN1419539A Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
05/21/2003CN1419534A Diphenyl ether compounds useful in therapie
05/21/2003CN1419532A Novel fatty acid analogous
05/21/2003CN1419453A Pharmaceutical gel composition
05/21/2003CN1419452A Synergistic methods and compositions for treating cancer
05/21/2003CN1419451A Novel galneical form for oral administration with prolonged release of molsidomine
05/21/2003CN1419450A Nitrite salts of antimicrobial agents
05/21/2003CN1419449A Sustained release oral preparations
05/21/2003CN1419448A Remedies
05/21/2003CN1419447A Diphenyl ketoaldehyde derivatives with anti-HIV activity
05/21/2003CN1419444A Pharmaceutical composition of topiramate
05/21/2003CN1419443A Continuous method for preparing pharmaceutical granules
05/21/2003CN1419442A Method of administering a medicinal aerosol formulation
05/21/2003CN1419439A Compositions and methods for treating hair loss using oximyl-and hydroxylamino-prostaglandins
05/21/2003CN1419438A Cosmetic and pharmaceutical compositions and methods usin 2-decarboxy-2-phophinico derivatives
05/21/2003CN1419437A Compositions and method for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
05/21/2003CN1419435A Skin preparations for extenal use
05/21/2003CN1419418A Method of producing oily suspensions of water-soluble vitamins
05/21/2003CN1419417A Carbohydrate system and a method for providing nutriton to a diabetic
05/21/2003CN1419411A Bacterial growth depressant or inhibitors with the use of 1,5-D-an hydrofructose
05/21/2003CN1419124A Method for controlling quality of compound red sage root preparation used for treating cardio-cerebral vascualr disease
05/21/2003CN1418966A Resoldution method for racemic compound of nucleoside enantiomorph
05/21/2003CN1418887A Aminoglycoside compound having antiviral activity
05/21/2003CN1418886A Dexketoprofen glueosceoctylamine and preparation process thereof and medicine composition having active composition of same
05/21/2003CN1418882A Substituted sulfonic N-[(amino imino methyl) phenyl alkyl]-acacycloamide compound
05/21/2003CN1418879A Process for preparing 8-methoxy-quinolone
05/21/2003CN1418872A 1,4-pentadiene-3-ketone compound containing halogenoindyl, and method for preparing same and medicinal use thereof
05/21/2003CN1418870A 3,4-dibidro-1H-anphthalene derivatives used as high selectivity inhibitor of cyclooxygenase-2
05/21/2003CN1418869A 2-propyl valeramide and 2-propyl pentaenuylamide derivative and application used as anti-convulsion medicine
05/21/2003CN1418687A Medicine composite for treating cough
05/21/2003CN1418685A Medicine composition for treating and its prepn. method
05/21/2003CN1418673A Method for extracting coxtex mouten total glucoside for treating hepatitis
05/21/2003CN1418662A Plant type composite sterilant used for mice
05/21/2003CN1418655A Aerosol for treating burn and scald, and its prepn-process
05/21/2003CN1418650A Spray agent for treating tendon and bone injury
05/21/2003CN1418640A Exterior use prepn. for treating skin trauma
05/21/2003CN1418639A Bc 1-2 gene antisense nucleotide prepn. used for treating nasopharyngeal carcinoma, and its application
05/21/2003CN1418638A Ribavirin oral disintegrant for treating virus influenza, and its prepn. method
05/21/2003CN1418637A Silicibinin-N-methylglucamine disperser for treating hepatitis, and its prepn. method
05/21/2003CN1418636A Compound prepn. contg. sophocarpidine and phosphatide, and its prepn. method
05/21/2003CN1418635A Aspirin oral disintegrant used for treating influenza and fever, and its prepn. method
05/21/2003CN1418634A Prednisolone oral disintegrant for treating acute bacterial infection, and its prepn. method
05/21/2003CN1418633A Anti-cancer assistant medicine contg. 20(S)-protopanaxadiol as effective component, and its application
05/21/2003CN1418632A Compound prepn. contg. ceftazidime and tazobactam for injection use
05/21/2003CN1418631A Zopiclone oral disintegrant for treating insomnia, and its prepn. method
05/21/2003CN1418630A Solution agent of antiallergi medicine contg. levocetirizine
05/21/2003CN1418629A Tipepidine oral disintegrant for treating tussis and expectoration, and its prepn. method
05/21/2003CN1418628A Fentanyl oral disintegrant for treating pain, and its prepn. method
05/21/2003CN1418627A Nitrophendipine oral disintegrant for treating angina pectoris, and its prepn. method
05/21/2003CN1418626A Nimodipine lipid nano particle compositions, and its prepn. method
05/21/2003CN1418625A Tetrahydropalmatine dispersion tablet for treating menalgia, and its prep. method
05/21/2003CN1418624A Alizapride oral disintegrant for treating emesis
05/21/2003CN1418623A Prepn. of obakulactone contd. medicine for treating hemorrhoid, and its use
05/21/2003CN1418622A Demethyl catharidine lipid for treating malignant tumour, and its prepn. method
05/21/2003CN1418621A WEILAPAMI oral disintegrant for treating irrhythmia, and its prepn. method
05/21/2003CN1418620A Quick disintegrated tablet or oral cavity disintegrated tablet containing L-glutamic acid and azulene sodium sulfonate and making method thereof
05/21/2003CN1418616A Cosmtics treatment using novel retinoid
05/21/2003CN1418565A Application method for silkworm medicine (together with folium mori)
05/21/2003CN1109108C Method for resolution of a racemic mixture of nucleoside enantioners
05/21/2003CN1109047C Amphiapathic moleculs as cholesterol and other lipid uptake inhibitors
05/21/2003CN1109041C Process for preparing substituted disulfide derivative and targeted form thereof
05/21/2003CN1109036C New process for prepn. of pharmacologically active substance
05/21/2003CN1109035C 12 position aryl-substituted arteannuin derivant preparation process and application thereof
05/21/2003CN1109034C Composition of gambogic acid compounds with anticancer activity and its preparing process
05/21/2003CN1109033C 8-subtituted-9H-1,3-dioxolo/4,5-h/2, 2/henzodiazepine derivatives, as Ampa/kainate receptor inhibitors
05/21/2003CN1109032C Compounds analogous to thalidomide from class comprising pipeidine-2,6-diones
05/21/2003CN1109031C Bicycle-aromatic compound
05/21/2003CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
05/21/2003CN1109026C Sidechain-beering taxanes like compounds
05/21/2003CN1109022C Arylalkanoyl pyridazines derivatives, its preparation method, medicine comprising samd and use thereof
05/21/2003CN1109016C Synthetic polyunsaturated fatty acid analogues
05/21/2003CN1108967C Metering valve
05/21/2003CN1108822C Pharmaceutical composition containing lornoxicam and disodic salt of EDTA
05/21/2003CN1108814C Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates
05/21/2003CN1108803C Medicine for treating piles and its preparing process
05/21/2003CN1108801C Phosphate-binding polymers for oral administration
05/21/2003CN1108800C Combined hormonal contraception pharmaceutical preparation
05/21/2003CN1108799C Use of K-252A derivative for treatment of peripheral or central nerve disorders, and cytokine overproduction
1 ... 5463 5464 5465 5466 5467 5468 5469 5470 5471 5472 5473 5474 5475 5476 5477 5478 5479 5480 5481 5482 5483 ... 7860